Cargando…
FOSB–PCDHB13 Axis Disrupts the Microtubule Network in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is among the leading causes of human mortality. One reason for high rates of NSCLC mortality is that drug resistance is a major problem for both conventional chemotherapies and less-toxic targeted therapies. Thus, novel mechanistic insights into disease pathogenesi...
Autores principales: | Ting, Chen-Hung, Lee, Kang-Yun, Wu, Sheng-Ming, Feng, Po-Hao, Chan, Yao-Fei, Chen, Yi-Chun, Chen, Jyh-Yih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357195/ https://www.ncbi.nlm.nih.gov/pubmed/30658436 http://dx.doi.org/10.3390/cancers11010107 |
Ejemplares similares
-
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer
por: Ting, Chen-Hung, et al.
Publicado: (2016) -
PCDHB15 as a potential tumor suppressor and epigenetic biomarker for breast cancer
por: Chiang, Ching-Chung, et al.
Publicado: (2022) -
Nile Tilapia Derived Antimicrobial Peptide TP4 Exerts Antineoplastic Activity Through Microtubule Disruption
por: Ting, Chen-Hung, et al.
Publicado: (2018) -
Thermostable small-molecule inhibitor of angiogenesis and vascular permeability that suppresses a pERK-FosB/ΔFosB–VCAM-1 axis
por: Li, Yue, et al.
Publicado: (2020) -
Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells
por: Carrier, Arnaud, et al.
Publicado: (2022)